6.96BMarket Cap
LossP/E TTM
Cidara Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-01-06The current valuation score of Cidara Therapeutics Inc is 6.29, ranking 306 out of 399 in the Biotechnology & Medical Research industry. Its current P/E ratio is -19.74, which is -100.00% below the recent high of 0.00 and 0.00% above the recent low of -19.74.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.